老虎证券

BUZZ-Australia's Cynata Therapeutics leaps as clinical trial progresses

Reuters
2025/12/15
BUZZ-Australia's <a href="https://laohu8.com/S/CYP.AU">Cynata Therapeutics</a> leaps as clinical trial progresses 

** Shares of Cynata Therapeutics CYP.AX rise as much as 7.6% to A$0.285, their highest level since December 1

** Stock set for its strongest trading session in over a week, if current trends hold

** Stem cell and regenerative medicine maker says 65 patients have been enrolled in its Phase 2 clinical trial of CYP-001 in adults diagnosed with acute graft versus host disease (aGvHD)

** aGvHD is a life-threatening complication where donor’s immune cells attack recipient's tissues

** Co says CYP-001 is designed to modulate immune system and improve both response rates and survival outcomes in aGvHD

** Stock up 18.6% YTD, including session's moves

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10